Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):659–665. doi: 10.1158/1055-9965.EPI-22-1038

Figure 2:

Figure 2:

Prevalence over time for White men (left) and Black men (right), assuming equal de novo and recurrent survival. Solid black line represents estimated number of new metastatic prostate cancer (MPC) cases; dashed blue line represents observed number of prostate cancer (PC) deaths; dotted red line indicates projections after 2018.